Table 1.
Results from the linear regression models examining the relationships between metabolites measured at 12 days and cognitive and somatic symptom burden at the 12 days assessment.
| HBI cognitive symptoms | HBI somatic symptoms | |||
|---|---|---|---|---|
| B (SE) = | p = | B (SE) = | p = | |
| tNAA | − 0.826 (0.74) | 0.267 | − 0.342 (0.49) | 0.481 |
| tCr | 0.599 (1.08) | 0.581 | 0.193 (0.71) | 0.785 |
| tCho | − 1.74 (2.11) | 0.41 | 0.568 (1.37) | 0.68 |
| Glx | − 0.09 (0.24) | 0.709 | − 0.004 (0.16) | 0.981 |
| mI | − 0.699 (0.78) | 0.372 | − 0.135 (0.51) | 0.792 |
| Age | 0.154 (0.19) | 0.418 | 0.587 (0.12) | 0.0001 |
| Sex | − 0.933 (0.91) | 0.304 | − 1.554 (0.59) | 0.009 |
| Site | 0.09 (0.31) | 0.774 | 0.334 (0.21) | 0.104 |
| Vendor | − 6.269 (2.21) | 0.005 | − 1.186 (1.44) | 0.41 |
The model controls for age, sex, site, and vendor. Significant values are in bold.